{"nct_id":"NCT02588612","title":"Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2016-02-01","start_date_type":"ACTUAL","primary_completion_date":"2020-08-10","primary_completion_date_type":"ACTUAL","completion_date":"2020-08-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}